These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8106114)

  • 21. Time course and magnitude of effects of changes in tonicity on acetylcholine release at frog neuromuscular junction.
    Kita H; van der Kloot W
    J Neurophysiol; 1977 Mar; 40(2):212-24. PubMed ID: 300428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ATP-sensitive K(+)-channel activators on transmitter release parameters at the frog neuromuscular junction.
    Salgado D; Shek EW; Alkadhi KA
    Brain Res; 1993 Apr; 609(1-2):307-12. PubMed ID: 8099524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primidone but not phenylethylmalonamide, a major metabolite, increases nerve-evoked transmitter release at the frog neuromuscular junction.
    Talbot PA; Alderdice MT
    J Pharmacol Exp Ther; 1982 Jul; 222(1):87-93. PubMed ID: 6123595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evoked transmitter release increased by inorganic mercury at frog neuromuscular junction.
    Manalis RS; Cooper GP
    Nature; 1975 Oct; 257(5528):690-1. PubMed ID: 241937
    [No Abstract]   [Full Text] [Related]  

  • 25. Barbiturates and transmitter release at the frog neuromuscular junction.
    Pincus JH; Insler NF
    Brain Res; 1981 May; 213(1):127-37. PubMed ID: 6113031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitroprusside inhibits neurotransmitter release at the frog neuromuscular junction.
    Lindgren CA; Laird MV
    Neuroreport; 1994 Oct; 5(16):2205-8. PubMed ID: 7865778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmitter release properties along regenerated nerve processes at the frog neuromuscular junction.
    Decino P
    J Neurosci; 1981 Mar; 1(3):308-17. PubMed ID: 6114997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in miniature end-plate potentials after brief nervous stimulation at the frog neuromuscular junction.
    Doherty P; Hawgood BJ; Smith IC
    J Physiol; 1984 Nov; 356():349-58. PubMed ID: 6335174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmitter mobilization at the frog neuromuscular junction.
    Alkadhi K; Volle RL
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):261-75. PubMed ID: 23083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in MEPP frequency during depression of evoked release at the frog neuromuscular junction.
    Zengel JE; Sosa MA
    J Physiol; 1994 Jun; 477(Pt 2):267-77. PubMed ID: 7932218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statistical parameters of transmitter release at frog neuromuscular junctions treated with guanidine or tetraethylammonium.
    Volle RL; Branisteanu DD
    J Pharmacol Exp Ther; 1976 Jun; 197(3):653-61. PubMed ID: 6788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the "calcium ionophore" A-23187 on transmitter release at the frog neuromuscular junction.
    Kita H; Madden K; Van der Kloot W
    Life Sci; 1975 Dec; 17(12):1837-41. PubMed ID: 3706
    [No Abstract]   [Full Text] [Related]  

  • 33. PTX-sensitive and -insensitive synaptic modulation at the frog neuromuscular junction.
    Sugiura Y; Ko CP
    Neuroreport; 2000 Sep; 11(13):3017-21. PubMed ID: 11006986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presynaptic effects of a trinitrobenzene analogue at the frog neuromuscular junction.
    Osanai M; Tsuji A; Suzuki N; Kijima H
    J Neurophysiol; 1996 Sep; 76(3):1735-43. PubMed ID: 8890288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dependence of spontaneous release at frog junctions on synaptic strength, external calcium and terminal length.
    Grinnell AD; Pawson PA
    J Physiol; 1989 Nov; 418():397-410. PubMed ID: 2576068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endotoxin alters spontaneous transmitter release at the frog neuromuscular junction.
    Person RJ
    J Neurosci Res; 1977; 3(1):63-72. PubMed ID: 23437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in transmitter release at frog neuromuscular junction induced by 4-aminopyridine].
    Molgo J; Lemeignan M; Lechat P
    C R Acad Hebd Seances Acad Sci D; 1975 Nov; 281(21):1637-9. PubMed ID: 3292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Ca2+ channel blockers on transmitter release and presynaptic currents at the frog neuromuscular junction.
    Katz E; Ferro PA; Cherksey BD; Sugimori M; Llinás R; Uchitel OD
    J Physiol; 1995 Aug; 486 ( Pt 3)(Pt 3):695-706. PubMed ID: 7473230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyneuronal innervation and quantal transmitter release in formamide-treated frog sartorius muscles.
    Herrera AA
    J Physiol; 1984 Oct; 355():267-80. PubMed ID: 6149312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.